Anti-glypican 3 antibodies

MYPI2025000960A0Undetermined Publication Date: 2023-04-15LEPU BIOPHARMA CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000960
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-02-10
Publication Date
2023-04-15
Patent Text Reader

Abstract

This disclosure provides anti-GPC3 antibodies, including murine antibodies, humanized antibodies, and those with further optimized CDR sequences. The newly disclosed antibodies exhibited higher cell-based binding efficiency than the leading anti-GPC3 antibody candidate under clinical development.
Need to check novelty before this filing date? Find Prior Art